Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia

Unrecognized genome instability syndromes can potentially impede the rational treatment of cancer in rare patients. Identification of cancer patients with a hereditary condition is a compelling necessity for oncologists, giving varying hypersensitivities to various chemotherapeutic agents or radiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Nils W., Schliffke, Simon, Schüller, Ulrich, Frenzel, Christian, Bokemeyer, Carsten, Kubisch, Christian, Lessel, Davor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540739/
https://www.ncbi.nlm.nih.gov/pubmed/31192125
http://dx.doi.org/10.3389/fonc.2019.00420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540739/
https://www.ncbi.nlm.nih.gov/pubmed/31192125
http://dx.doi.org/10.3389/fonc.2019.00420

Ejemplares similares